NEWSROOM

Get the latest Terumo Aortic news featuring our tailored thoracic,
thoracoabdominal and abdominal devices.

Terumo Creates Global Group Music

Terumo Corporation (TSE: 4543) today announced the creation of the company’s global Group Music in conjunction with Terumo’s 100th anniversary in 2021.

Terumo Aortic announces commercial launch of TREO Abdominal Stent Graft System in the United States

Following approval this year by the US Food and Drug Administration (FDA) of the TREO® Abdominal Aortic Stent-Graft System for the treatment of patients with abdominal aortic aneurysms (AAA), Terumo Aortic announced today the commercial launch of this endovascular device.

Terumo Aortic announces US FDA Approval for TREO endovascular device

Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the TREO® Abdominal Aortic Stent-Graft System for sale in the United States for the treatment of patients with abdominal aortic aneurysms (AAA).



For more updates on Terumo Aortic, follow us on Twitter or LinkedIn.

MEDIA ENQUIRIES

Please reach out to our media relations contact for
press enquiries about our innovative solutions.


Carrie White
Head, Global Marketing Communications
+44 (0) 141 812 5555